Opnurasib is an orally potent and selective covalent KRAS G12C inhibitor with antitumor activity that can be used to study advanced non-small cell lung cancer.
- Size: 1mg
- Purity: ≥98%
- Brand: Saint Michael
- Catalogue No.: IO2670-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review